Trial · NCT00513305
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 16 of 16
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants in Complete Remission (CR) | Low-dose Cytarabine Plus Arsenic Trioxide | 15.2 | 0.051 to 0.319 | Percentage of participants in CR | |
| Percentage of Participants in Complete Remission (CR) | Low-dose Cytarabine Alone | 8.8 | 0.019 to 0.0237 | Percentage of participants in CR | |
| Number of Participants Who Died or Were Censored by 24 Months | Low-dose Cytarabine Plus Arsenic Trioxide | 33 | Participants | ||
| Number of Participants Who Died or Were Censored by 24 Months | Low-dose Cytarabine Alone | 34 | Participants | ||
| Proportion of Participants With Relapse-Free Survival (RFS)Using the Kaplan-Meier Estimate | Low-dose Cytarabine Plus Arsenic Trioxide | Month 3 (95% Confidence Interval) | 0.818 | 95% Confidence Interval 0.447 to 0.951 | Proportion of participants |
| Proportion of Participants With Relapse-Free Survival (RFS)Using the Kaplan-Meier Estimate | Low-dose Cytarabine Alone | Month 3 (95% Confidence Interval) | 0.800 | 95% Confidence Interval 0.204 to 0.969 | Proportion of participants |
| Proportion of Participants With Relapse-Free Survival (RFS)Using the Kaplan-Meier Estimate | Low-dose Cytarabine Plus Arsenic Trioxide | Month 6 (95% Confidence Interval) | 0.818 | 95% Confidence Interval 0.447 to 0.951 | Proportion of participants |
| Proportion of Participants With Relapse-Free Survival (RFS)Using the Kaplan-Meier Estimate | Low-dose Cytarabine Alone | Month 6 (95% Confidence Interval) | 0.800 | 95% Confidence Interval 0.204 to 0.969 | Proportion of participants |
| Number of Participants Who Experienced Early Death | Low-dose Cytarabine Plus Arsenic Trioxide | 0 | Participants | ||
| Number of Participants Who Experienced Early Death | Low-dose Cytarabine Alone | 2 | Participants | ||
| Number of Participants Who Experienced Induction (Thirty-Day) Mortality | Low-dose Cytarabine Plus Arsenic Trioxide | 3 | Participants | ||
| Number of Participants Who Experienced Induction (Thirty-Day) Mortality | Low-dose Cytarabine Alone | 2 | Participants | ||
| Proportion of Participants Surviving at 6 Months and 12 Months Using the Kaplan Meier Estimate | Low-dose Cytarabine Plus Arsenic Trioxide | Month 6 (95% Confidence Interval) | 0.626 | 95% Confidence Interval 0.435 to 0.768 | Proportion of Participants |
| Proportion of Participants Surviving at 6 Months and 12 Months Using the Kaplan Meier Estimate | Low-dose Cytarabine Alone | Month 6 (95% Confidence Interval) | 0.649 | 95% Confidence Interval 0.454 to 0.789 | Proportion of Participants |
| Proportion of Participants Surviving at 6 Months and 12 Months Using the Kaplan Meier Estimate | Low-dose Cytarabine Plus Arsenic Trioxide | Month 12 (95% Confidence Interval) | 12.22 | 95% Confidence Interval 4.37 to 16.76 | Proportion of Participants |
| Proportion of Participants Surviving at 6 Months and 12 Months Using the Kaplan Meier Estimate | Low-dose Cytarabine Alone | Month 12 (95% Confidence Interval) | 8.51 | 95% Confidence Interval 5.72 to 19.65 | Proportion of Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00513305/results